Nabi Biopharmaceuticals (NABI) Reports Q4 Loss of $0.05

March 14, 2012 4:15 PM EDT
Get Alerts NABI Hot Sheet
Trade NABI Now!
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q4 EPS of ($0.05), versus ($0.08) reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment